Table 4 QTcF profiles of patients who received bedaquiline-containing regimen in the cohort
Variable | Patients (n = 1162), n (%) |
|---|---|
Median QTcF at baseline (IQR), ms | 413 (398, 429) |
Median change in QTcF from baseline to week 24 (IQR), ms | 16 (−3, 35) |
Worsening QTcF from baseline to follow-up, n (%) | |
 n | 1044 |
  ≥ 450 ms | 424 (40.6) |
  ≥ 500 ms | 32 (3.1) |
Change in QTcF from baseline, n (%) | |
 n | 839 |
  ≥ 30 ms | 439 (52.3) |
  ≥ 60 ms | 132 (15.7) |